The drh-3(fj52) mutant was isolated from a deletion mutant library of the K.
2 ligated by fill-in PCR, and a fusion gene (rpl-21 promoter::gfp::his-tag::rrf-1 coding region) was made. The fusion gene and pMH86 (plasmid carrying dpy-20) were co-injected into rrf-1(pk1417); dpy-20(e2017) mutants. Animals whose transgenes were stably integrated into chromosomes were selected after UV irradiation.
Antibodies
The following polyclonal antibodies were raised in rabbits. New anti-RDE-4 antibodies were raised against a recombinant protein corresponding to a region (amino acid residues 207-385) of RDE-4. Anti-DCR-1 antibodies were raised against a synthetic peptide (CRDDRMDGEDQDT-amide) and were used for immunoprecipitation. Anti-DRH-3 antibodies were raised against a synthetic peptide (Ace-AIRLEDYDKSKLRLC). The anti-DRH-3 antibodies worked for immunoblotting, but not for immunoprecipitation.
Anti-CSR-1 antibodies were raised against a recombinant protein corresponding to a region (amino acid residues 2-416) of CSR-1.
Additional anti-DCR-1 polyclonal antibodies were raised in rats. These antibodies were raised against a recombinant protein corresponding to a region (amino acid residues 965-1307) of DCR-1.
Anti-GFP monoclonal antibody (3E6, Wako) was used for immunoprecipitation.
Anti-GFP polyclonal antibodies (sc-8334, Santa Cruz) and anti-GAPDH monoclonal antibody (MAB374, Chemicon) were used for immunoblotting.
Immunoblotting experiments were performed as follows. In cases where the concentrations of samples were more than 0.5 mg/ml protein, samples were mixed with an equal volume of 2X SDS/urea gel-loading buffer (8 M urea, 25 mM Tris-HCl (pH6.8), 2% -mercaptoethanol, 1 mM EDTA, and bromophenol blue) and heated at 70°C for 5 min.
Samples with low protein concentrations were mixed with conventional SDS/glycerol gel-loading buffer and boiled for 3 min. Then, SDS-treated samples were resolved by SDS PAGE and blotted onto PVDF membranes. The membranes were blocked with skim milk 3 solution and subsequently incubated with primary antibodies diluted in Can-Get-Signal enhancer solution (Toyobo, Japan).
Immunoprecipitation was performed using immobilized antibodies. Anti-RDE-4 and anti-DCR-1 antibodies were bound to Protein A ultralink resin (Pierce), and anti-GFP monoclonal antibody was bound to GammaBind G sepharose (GE). The antibodies were crosslinked to the beads using dimethyl pimelimidate. mixed with TE-saturated phenol and shaken vigorously for 2 min. The supernatant containing the dsRNA was recovered after centrifugation and applied onto a G-50 spin column. The eluate from the spin column was electrophoresed on a 6% native PAGE gel, and a gel piece containing the dsRNA was agitated in elution buffer (0.5 M ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA and 0.1% SDS) overnight. The eluted dsRNA was extracted with PCI (phenol, chloroform, and isoamyl-alcohol) and chloroform and subsequently precipitated with ethanol and co-precipitant (ethachinmate, NipponGene).
RNAs for enzymatic assays
The dsRNA was resuspended in 5 mM HEPES-KOH (pH 7.6) and used for assays.
For the Slicer assay, radiolabeled mRNAs and synthetic siRNAs were used. First, a plasmid (pHIT88) was constructed to have a T7 promoter, restriction enzyme sites for cloning, poly-A (61 x A), and a BsaI site. The BsaI site was designed to cut the 3' region of the poly-A sequence in the plasmid, and so the 3' end of the transcript from the linearized plasmid has a complete poly-A (60 x A) structure. A portion of the F46H5.3 cDNA was cloned into pHIT88, and a 393 nt mRNA was transcribed from the plasmid using T7 RNA polymerase. The 5' end of the mRNA was radiolabeled with [ -32 P] GTP (3,000 Ci/mmol) and Vaccinia virus capping enzyme (guanylyl transferase) as described by Haley et al (2003) .
The labeled mRNA was purified by electrophoresis. was treated with 0.6 mg/ml Proteinase K to inactivate RNases, and subsequently with PCI and chloroform. The dsRNA was purified by electrophoresis.
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RdRP assay on immunoprecipitates
The RdRP activity of the GFP::RRF-1 fusion protein was assayed as follows.
Transgenic animals expressing GFP::RRF-1 were agitated in 10 mM DTT and 25 mM borate-NaOH (pH 9) for 7 min and subsequently washed three times with TBS. One volume of animals was mixed with 6 volumes of IP buffer (150 mM NaCl, 25 mM HEPES-NaOH (pH 7.4), 10% glycerol, 1% Triton-X, and 1X complete protease inhibitors (Roche)) and homogenized. The homogenate was centrifuged 4 times, and the supernatant was filtrated with a syringe filter. For the typical RdRP assay, immunoprecipitates from 0.6 ml of detergent-extracted lysate were used in each reaction. First, the lysate was pre-absorbed 
Cloning of RdRP products
An RdRP reaction was performed with GFP::RRF-1 immunoprecipitates, 25 ng/Cl RNA template (1299 nt), and 1mM each ribonucleotide at 25°C for 2 h. The reaction was 6 stopped by treatment with 1 mg/ml Proteinase K in PK buffer containing 0.4 M NaCl at 50°C
for 30 min. RNAs were extracted with PCI and chloroform, and precipitated with ethanol.
To select regions where the RdRP products and the template RNA were hybridized, the RNAs were treated with 7 >g/ml RNase A and 0.35 >g/ml RNase T1 in buffer (0.5 M NaCl, 20 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 0.1% Tween-20) at 25°C for 30 min. The
RNase reaction was stopped by treatments with Proteinase K and SDS, and subsequently with PCI and chloroform. Protected RNAs were precipitated with ethanol, and resuspended in 10 mM Tris-HCl (pH 6.8).
Cloning of the small RdRP products was performed with a strategy combining techniques described by Fu et al (2005) and Clepet et al (2004) . The protected RNAs were heat-denatured and subsequently polyadenylated with 12 units/>l yeast poly-A polymerase (USB Corp.) and 1.5 mM ATP at 30°C for 1.5 h. The RNA products were extracted with PCI and chloroform, and precipitated with ethanol. To convert the triphosphorylated ends of RdRP products into monophosphorylated ends, the RNAs were treated with 0.23 unit/>l
Tobacco acid pyrophosphatase at 37°C for 1 h. The RNA products were again extracted with PCI and chloroform, and precipitated with ethanol. Resuspended RNAs were heated at 65°C for 2 min, and subsequently reacted with 2 >M double-stranded adapter and T4 DNA ligase supplied in buffer containing ATP and polyethylene glycol at 16°C for 1 h. The double-stranded adapter is a duplex consisting of an RNA oligonucleotide (AUUUCGAAGUACUCAGCGUAAGUGA) and a DNA oligonucleotide (NNNNNNTCACTTACGC-amide; N is degenerate), and the DNA strand of the adapter acts to splint the RNA strand of the adapter and the 5' end of sample RNAs. Adapter-ligated RNAs were treated with DNase I to remove the DNA splint, and subsequently extracted with PCI and chloroform. To reduce free adapter molecules, the RNAs were passed through a G-75 spin column and precipitated with ethanol.
The RNA products were reverse-transcribed with AMV reverse transcriptase and anchored oligo(dT) primers (CTGGTCTAGATAAACCTGTCTTTTTTTTTTTTTTTTV; V 7 represents a mixture of 0.3 DM dA, 0.2 DM dG and 0.2 DM dC) at 45°C for 50 min. cDNAs were passed through a G-75 spin column, and heated at 80°C for 5 min to inactivate the reverse transcriptase. The cDNAs were subjected to PCR using adapter primers (GCGAATTCTGAAGTACTCAGCGTAAGTG; CTGGTCTAGATAAACCTGTCT). The
RT-PCR products corresponding to 10-40 nt RNAs were purified by electrophoresis, cut with restriction enzymes (EcoRI and XbaI) and cloned into a plasmid.
Primer extension assay
The 5' end of siRNA No.7 was labeled with [ -32 P] ATP and T4 kinase.
GFP::RRF-1 immunoprecipitates or the high-MW fraction of cell lysates were reacted at 25°C for 2 h with 10 nM radiolabled siRNA, 25 ng/Dl template mRNA (393 nt) and 1 mM ribonucleotides. The reaction buffer was the same as that used in the basic conditions for the in vitro assay. The reaction with the high-MW fraction contained creatine phosphate and creatine kinase. As a positive control, AMV reverse transcriptase (final 0.35 unit/Dl) and deoxyribonuleotides were reacted at 42°C with the same concentrations of labeled siRNA and template mRNA. Reaction products were analyzed on a 6% sequencing gel.
Sucrose gradient analysis
A cytoplasmic lysate from a transgenic animal expressing GFP::RRF-1 was prepared according to the method for standard lysates, but the treatment with the C column was omitted. Sucrose gradient centrifugation was performed as described by Matsumoto et al (2000) .
RT-PCR analysis of mRNA cleaved by Slicer activity
Slicer reactions were set up with single-stranded siRNAs and target mRNA, and the 5' cleavage fragments of the mRNAs were recovered. The recovered RNAs were ligated with an oligonucleotide adapter (pCAUaaccgcgaattccag-amide; the RNA sequence is in 
